Posts - Bill - HR 1262 Give Kids a Chance Act of 2025
house 02/12/2025 - 119th Congress
We are working to improve how pediatric cancer drugs are studied and developed by enhancing FDA oversight of molecularly targeted treatments, ensuring timely completion of pediatric studies, and encouraging new therapies for rare childhood cancers. This legislation aims to accelerate safe and effective cancer treatments specifically designed for kids.
Congress.gov
HR 1262 - Give Kids a Chance Act of 2025
Views
left-leaning 02/12/2025
Finally, a bill that puts kids’ health over corporate profits—about time we put science first, not shareholder dividends.
moderate 02/12/2025
Balancing innovation with oversight—this act tries to thread the needle between fast cures and safety nets.
left-leaning 02/12/2025
If saving kids with targeted treatments isn’t bipartisan, what is? This is healthcare done right, no corporate pinky-swears needed.
moderate 02/12/2025
Pediatric cancer says 'urgency,' Congress says 'process'—let’s hope this bill keeps pace with both.
moderate 02/12/2025
A pragmatic push to close the pediatric cancer treatment gap—progress without the usual political circus.
right-leaning 02/12/2025
Sure, save the kids—but don’t expect more red tape or government drones slowing down innovation.
left-leaning 02/12/2025
Pediatric cancer gets the spotlight it deserves; maybe Congress can learn to care about more than just the bottom line.
right-leaning 02/12/2025
Good to see enforcement balanced with due diligence—accountability shouldn’t mean killing progress in a bureaucratic chokehold.
right-leaning 02/12/2025
Priority review vouchers: a smart carrot for rare diseases, not just another handout to Big Pharma.